Latest updates for Teva

Fresh curated links around teva are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Teva's Turnaround Is Working. Here's the 1 Thing That Could Send It Soaring Another 50%.
  • Teva Seeks to Keep Israel Ties From Philadelphia Jury, Cites Gaza War
  • Will Israel's Teva's new celiac medication be the best thing since sliced bread?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /1 month ago

Teva's Turnaround Is Working. Here's the 1 Thing That Could Send It Soaring Another 50%.

The pharmaceutical company has a likely blockbuster drug as the flagship of its pipeline.

Read source
insurancejournal.com /4 weeks ago

Teva Seeks to Keep Israel Ties From Philadelphia Jury, Cites Gaza War

Teva Pharmaceuticals has asked a U.S. judge to prevent insurer Humana from telling jurors it is an Israeli company at a major drug price-fixing trial, arguing that strong public vi...

Read source
haaretz.com /1 week ago

Will Israel's Teva's new celiac medication be the best thing since sliced bread?

Israeli giant Teva announced positive results in an ongoing study of a new antibody, that protects sufferers of the disease from harm triggered by gluten

Read source
fiercebiotech.com /1 week ago

Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio

BioXcel Therapeutics has filed for bankruptcy and lined up a deal for Teva Pharmaceutical to acquire its assets for $57.5 million upfront.

Read source
pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals]]>

Read source
biopharmadive.com /1 week ago

Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute

Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.

Read source
law360.com /1 month ago

Judge OKs $35M Teva Deal In Delayed Generic Inhalers Suit

A Massachusetts federal judge has approved an antitrust settlement that will see Teva Pharmaceuticals pay $35 million to resolve claims that it schemed to delay generic competition...

Read source
law360.com /1 month ago

7th Circ. Revives Teva Suit Over Eli Lilly Generic Drug Block

The Seventh Circuit on Monday revived a breach-of-contract lawsuit against Eli Lilly, ruling that an earlier legal settlement under which Eli Lilly agreed not to block the approval...

Read source
haaretz.com /1 month ago

Pharma giant Teva seeks to hide Israel ties from U.S. jury in price-fixing trial

The company argued that strong public views over the Gaza war could prejudice proceedings and affect its ability to receive a fair hearing. The filing underscored how tensions over...

Read source
fiercebiotech.com /1 week ago

Teva autoimmune antibody notches ph. 2 win in celiac disease

Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive after the Israeli outfit’s anti-interleukin-15 antibody scored a midstage win in celiac...

Read source
medcitynews.com /6 days ago

Teva Drug Rises to the Gluten Challenge, Stopping Intestinal Damage in Celiac Disease Trial

In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — eating food with gluten to see if it prompts an immune r...

Read source
seekingalpha.com /1 week ago

BioXcel files for Chapter 11, will sell assets to Teva

Read source
finance.yahoo.com /1 month ago

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Teva

finance.yahoo.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source